Shopping Cart 0
Cart Subtotal
USD 0

Occlusive Coronary Artery Disease Global Clinical Trials Review, H1, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Occlusive Coronary Artery Disease Global Clinical Trials Review, H1, 2018

Summary

GlobalData's clinical trial report, "Occlusive Coronary Artery Disease Global Clinical Trials Review, H1, 2018" provides an overview of Occlusive Coronary Artery Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Occlusive Coronary Artery Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Occlusive Coronary Artery Disease Therapeutics Clinical Trials 27

Prominent Drugs 28

Clinical Trial Profile Snapshots 29

Appendix 40

Abbreviations 40

Definitions 40

Research Methodology 41

Secondary Research 41

About GlobalData 42

Contact Us 42

Source 42


List Of Figure

List of Figures

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14

Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 15

Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 18

Occlusive Coronary Artery Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Phase (%), 2018* 20

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 21

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24

Occlusive Coronary Artery Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 25

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28

GlobalData Methodology 41


List Of Table

List of Tables

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Region, 2018* 7

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, North America, Top Countries, 2018* 12

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14

Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 15

Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 18

Occlusive Coronary Artery Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Phase, 2018* 20

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 21

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24

Occlusive Coronary Artery Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 25

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

AstraZeneca Plc Bristol-Myers Squibb Co Eli Lilly and Co Sanofi Matrizyme Pharma Corp Johnson & Johnson Daiichi Sankyo Co Ltd B. Braun Melsungen AG Abbott Laboratories

Occlusive Coronary Artery Disease Global Clinical Trials Review, H1, 2018

Summary

GlobalData's clinical trial report, "Occlusive Coronary Artery Disease Global Clinical Trials Review, H1, 2018" provides an overview of Occlusive Coronary Artery Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Occlusive Coronary Artery Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Occlusive Coronary Artery Disease Therapeutics Clinical Trials 27

Prominent Drugs 28

Clinical Trial Profile Snapshots 29

Appendix 40

Abbreviations 40

Definitions 40

Research Methodology 41

Secondary Research 41

About GlobalData 42

Contact Us 42

Source 42


List Of Figure

List of Figures

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14

Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 15

Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 18

Occlusive Coronary Artery Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Phase (%), 2018* 20

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 21

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24

Occlusive Coronary Artery Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 25

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28

GlobalData Methodology 41


List Of Table

List of Tables

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Region, 2018* 7

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, North America, Top Countries, 2018* 12

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14

Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 15

Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 18

Occlusive Coronary Artery Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Phase, 2018* 20

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 21

Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24

Occlusive Coronary Artery Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 25

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27

Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

AstraZeneca Plc Bristol-Myers Squibb Co Eli Lilly and Co Sanofi Matrizyme Pharma Corp Johnson & Johnson Daiichi Sankyo Co Ltd B. Braun Melsungen AG Abbott Laboratories